We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.18 | 0.40% | 44.88 | 45.37 | 44.34 | 44.73 | 21,281,928 | 01:00:00 |
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Monday, June 1, 2015, at 7 p.m. EDT (6 p.m. CDT) to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com, by dialing (647) 788-4901 or (877) 201-0168, confirmation code: 4580465. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 10:30 p.m. EDT on June 1 through 11:59 p.m. EDT on June 8. The replay can be accessed at http://investor.bms.com or by dialing (855) 859-2056, confirmation code: 4580465.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150528006391/en/
Bristol-Myers SquibbMedia:Ken Dominski, 609-252-5251ken.dominski@bms.comorInvestors:Ranya Dajani, 609-252-5330ranya.dajani@bms.comorBill Szablewski, 609-252-5894william.szablewski@bms.com
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions